Alginate-based membranes containing hyaluronic acid (HA) were manufactured by freeze-drying calcium-reticulated hydrogels. The study of the distribution of the two macromolecules within the hydrogel enabled to highlight a polymer demixing mechanism that tends to segregate HA in the external parts of the constructs. Resistance and pliability of the membranes were tuned, while release and degradation studies enabled to quantify the diffusion of both polysaccharides in physiological solution and to measure the viable lifetime of the membranes. Biological studies in vitro proved that the liquid extracts from the HA-containing membranes stimulate wound healing and that fibroblasts are able to colonize the membranes. Overall, such novel alginate-HA membranes represent a promising solution for several medical needs, in particular for wound treatment, giving the possibility to provide an in situ administration of HA from a resorbable device.
Hyaluronan delivery by polymer demixing in polysaccharide-based hydrogels and membranes for biomedical applications
TRAVAN, Andrea;SCOGNAMIGLIO, FRANCESCA;BORGOGNA, MASSIMILIANO ANTONIO;MARSICH, ELEONORA;DONATI, IVAN;TARUSHA, LORENA;GRASSI, Mario;PAOLETTI, SERGIO
2016-01-01
Abstract
Alginate-based membranes containing hyaluronic acid (HA) were manufactured by freeze-drying calcium-reticulated hydrogels. The study of the distribution of the two macromolecules within the hydrogel enabled to highlight a polymer demixing mechanism that tends to segregate HA in the external parts of the constructs. Resistance and pliability of the membranes were tuned, while release and degradation studies enabled to quantify the diffusion of both polysaccharides in physiological solution and to measure the viable lifetime of the membranes. Biological studies in vitro proved that the liquid extracts from the HA-containing membranes stimulate wound healing and that fibroblasts are able to colonize the membranes. Overall, such novel alginate-HA membranes represent a promising solution for several medical needs, in particular for wound treatment, giving the possibility to provide an in situ administration of HA from a resorbable device.File | Dimensione | Formato | |
---|---|---|---|
Hyaluronan delivery.pdf
Accesso chiuso
Descrizione: Articolo principale
Tipologia:
Documento in Versione Editoriale
Licenza:
Digital Rights Management non definito
Dimensione
2.21 MB
Formato
Adobe PDF
|
2.21 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
CARBPOL-D-16-00212R2.pdf
Open Access dal 01/04/2017
Tipologia:
Bozza finale post-referaggio (post-print)
Licenza:
Creative commons
Dimensione
3.14 MB
Formato
Adobe PDF
|
3.14 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.